ARTICLE | Clinical News
Anidulafungin: NDA submitted
August 22, 2005 7:00 AM UTC
MICU submitted an NDA to FDA for anidulafungin to treat invasive candidiasis/candidemia. The application includes data from a Phase III trial that showed the superiority of anidulafungin to fluconazol...